R. Brigg Turner, PharmD, BCPS-AQ ID

Phone Number: 
503-352-7288
UC Box: 
A192
Office Location: 
Creighton Hall 452

Block Coordinator

PHRM 681 | Infectious Diseases I

PHRM 682 | Infectious Diseases II

PHRM 686 | Infectious Diseases III

Education

2013 | PGY-2 Infectious Diseases Pharmacy Residency, West Virginia University Healthcare, Morgantown, W.V. 

2012 | PGY-1 Pharmacy Residency, West Virginia University Healthcare, Morgantown, W.V. 

2011 | Doctor of Pharmacy, Lake Erie College of Osteopathic Medicine, Erie, Pa. 

2007 | Bachelor of Science, Neuroscience, Brigham Young University, Provo, Utah

Areas of Research & Specialization

Interest areas include infectious diseases, antimicrobial resistance, antimicrobial stewardship, and pharmacokinetics/pharmacodynamics of antimicrobials.

Clinical Practice Site

Legacy Health, Emanuel Medical Center, Portland, OR.

Select Publications

Klepser ME, Dobson EL, Pogue JM, Labreche MJ, Adams AJ, Gauthier TP, Turner RB, Su CP, Jacobs DM, Suda KJ. A call to action for outpatient antibiotic stewardship. J Am Pharm Assoc (2003);2017, epub ahead of print.

Dobson EL, Klepser ME, Pogue JM, Labreche MJ, Adams AJ, Gauthier TP, Turner RB, Su CP, Jacobs DM, Suda KJ. Outpatient antibiotic stewardship: interventions and opportunities. J Am Pharm Assoc (2003);2017, epub ahead of print.

Turner RB, Valcarlos E, Loeffler AM, Gilbert M, Chan D. Impact of an antimicrobial stewardship program on antibiotic use at a non-freestanding children’s hospital. J Pediatric Infect Dis Soc 2016; https://doi.org/10.1093/jpids/piw059; epub ahead of print.

Turner RB, Valcarlos C, Won R, Chang E, Schwartz J. Impact of infectious diseases consultation on clinical outcomes of patients with Staphylococcus aureus bacteremia at a community health system. Antimicrob Agents Chemother 2016;60:5682-5687.

Bath S, Lines J, Loeffler AM, Malhotra A, Turner RB. Impact of standardization of antimicrobial prophylaxis duration in pediatric cardiac surgery. J Thorac Cardiovasc Surg 2016;152:1115-1120.

Turner RB, Cumpston A, Sweet M, Briggs F, Slain D, Wen S, Craig M, Hamadani M, Petros W. A prospective, controlled study of acyclovir pharmacokinetics in obese patients. Antimicrob Agents Chemother 2016;60(3):1830-1833.

Turner RB, Rouse S, Elbarbry F, Wanek S, Grover V, Chang E. Azithromycin pharmacokinetics in adults with acute respiratory distress syndrome undergoing treatment with extracorporeal-membrane oxygenation. Ann Pharmacother 2016;50:72-73.

Turner RB, Elbarbry F, Biondo L. Pharmacokinetics of once and twice daily dosing of intravenous tobramycin in paediatric patients with cystic fibrosis. J Chemother 2015;28:304-307.

Turner RB, Martello JL, Malhotra A. Worsening renal function in patients with baseline renal impairment treated with intravenous voriconazole: A systematic review. Int J Antimicrob Agents 2015;46:362-366.

Turner RB, Smith CB, Martell JL, Slain D. Role of doxycycline in Clostridium difficile infection acquisition. Ann Pharmacother 2014;48:772-6. 

Select Poster Presentations

Bradley B, Turner RB, Saito E, Doyle I, Copper-DeHoff R. MeRIT Project: Impact of standard of care implementation on prescriber adoption of opiate MED recommendation in a federally qualified health center [abstract]. 2017 American College of Clinical Pharmacy Virtual Poster Symposium: May 2017.

Saedi-Kwon H, Schwartz J, Turner RB. Incidence of neutropenia with long-term ceftaroline therapy [abstract 5a-190]. 51st Midyear Clinical Meeting, American Society of Health-System Pharmacists, Las Vegas, NV: December 2016.

Jacobson S, Esber Z, Turner RB, Bowman MC. Comparison of treatment outcomes between minocycline, trimethoprim-sulfamethoxazole, and fluoroquinolone monotherapy for Stenotrophomonas maltophilia infections [abstract 2028]. IDWeek 2016, New Orleans, LA: October 2016.

Turner RB, Valcarlos E, Won R. Impact of infectious diseases consultation and polymerase chain reaction on clinical outcomes of Staphylococcus aureus bacteremia at a community health system [abstract S-896]. 55th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA: September 2015.

Chavez B, Turner RB, Hughes J, Wegrzyn N, Fortner J, Fuentes D. The progression of electronic health record implementation into a pharmacy curriculum [abstract]. Monash University International Pharmacy Education Symposium, Prata, Italy: July 2015.

Bath S, Turner RB, Lines J, Malhotra A, Loeffler A.  Impact of standardization of duration of antibiotic prophylaxis for prevention of surgical site infections in pediatric cardiac surgery. [podium] 55th Interscience Conference on Antimicrobial Agents and Chemotherapy, September 2015, San Diego, CA. 

Turner RB, Cumpston A, Sweet M, Briggs F, Slain D, Wen S, Craig M, Hamadani M, Petros W. A Prospective, Controlled Study of Acyclovir Pharmacokinetics in Obese Patients [abstract A-707]. 54th Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society of Microbiology, Washington DC: September 2014.

Turner RB, Cummiskey B, Kojiro K, Chang E, Michaels A. Vancomycin Pharmacokinetics in Adult Patients Receiving Extracorporeal Membrane Oxygenation [A-1313]. 54th Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society of Microbiology, Washington DC: September 2014.

Loeffler AM, Valcarlos E, Turner RB, Little M, Gilbert M. Antimicrobial Stewardship Pilot Project at Randall Children’s Hospital. [podium] 5th Annual International Pediatric Antimicrobial Stewardship Conference, Pediatric Infectious Diseases Society; Kansas City, MO: June 2014.

Turner RB, Biondo L, Slain D, Phillips U, Cardenas S, Moffett K. A Randomized Pilot Study of Continuous Versus Intermittent Infusion Piperacillin-Tazobactam for the Treatment of Pulmonary Exacerbations in Patients with Cystic Fibrosis [abstract 332]. Annual North American Cystic Fibrosis Conference, Salt Lake City, UT: October 2013.

Kirk H, Turner RB, Sweet M, LaSala PR, Slain D, Khakoo R. Comparison of Methicillin-Resistant Staphylococcus aureus Contamination Rates of Medication Cabinets Between Isolation and Non-Isolation Rooms [abstract 1690]. IDWeek 2013, San Francisco, CA: October 2013.

Turner RB, Keller L, Slain D, Petros K, Sarwari A. Prolonged Infusion of Cephalosporins Did Not Improve Outcomes in Gram-Negative Infections in the Clinical Setting [abstract K-718]. 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society of Microbiology, Denver, CO: September 2013.

Chinikailo M, Kurdelchuk O, Turner RB, Devi SS. Assessment of poison control centers’ current guidelines on acetaminophen toxicity treatment management [abstract]. Annual Spring Meeting, Allegheny-Erie Society of Toxicology, Pittsburgh, PA: April 2010.

Turner RB, Vroman B, Ulisse C, Mehta A, Corso T, Devi SS. Primed mice are protected from liver injury following a normally lethal dose of acetaminophen [abstract]. Annual Spring Meeting, Allegheny-Erie Society of Toxicology, Pittsburgh, PA: April 2010.

Hours: 

By Appointment

Area of Study I Teach (Graduate/Professional):